Market Cap (In AUD)
3.26 Million
Revenue (In AUD)
12.5 Thousand
Net Income (In AUD)
-1.15 Million
Avg. Volume
94.77 Thousand
- Currency
- AUD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.016-0.032
- PE
- -
- EPS
- -
- Beta Value
- 0.418
- ISIN
- AU000000NC68
- CUSIP
- Q6518Q106
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Dr. Wayne Morris Best BSc (Hons), DIC, FRACI, GAICD, Ph.D.
- Employee Count
- -
- Website
- https://www.nanollose.com
- Ipo Date
- 2017-10-17
- Details
- Nanollose Limited, a biomaterials company, engages in the research and development, and promotion of the microbial nanocellulose technology in Australia. The company offers Nullarbor Fibre, a tree-free Nullarbor lyocell fibre; and Jelli Grow, an alternative seed germination and plant growing material. Its products are used in textiles, nonwoven fabric, and other industries. The company was incorporated in 2014 and is based in Nedlands, Australia.
More Stocks
-
NETWORK18Network18 Media & Investments Limited
NETWORK18
-
8043
-
7199
-
NATPLY
-
CTCL
-
MSTH
-
ILTYillimity Bank S.p.A.
ILTY
-
RPGLIFERPG Life Sciences Limited
RPGLIFE